Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 734

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 11
Chunk 734
---
$1,500 millionFebruary 15, 20545.600%$1,485 millionAugust 15, 205320(1) Redeemable at any time prior to this date at a "make whole" premium, defined below. Redeemable at par on or after this date.(2) "Make whole" premium calculated using the most directly comparable U.S. Treasury rate plus the amount of basis points set forth in this column. In the first quarter of 2024, the Company completed the repurchase of $1.7 billion in aggregate principal amount of existing senior notes that were tendered to the Company pursuant to cash tender offers.

Debt Maturities. Maturities of the Company's long-term debt are as follows:(In millions) 2025$1,973 2026$2,301 2027$2,056 2028$3,800 2029$1,000 Maturities after 2029$19,292 Debt Covenants. The Company was in compliance with its debt covenants as of December 31, 2024.Note 3 - The Company's intercompany receivables consist primarily of net intercompany loan amounts due from Evernorth Health, Inc. of $8.5 billion as of December 31, 2024 and 2023. Interest income on the loan receivable was accrued at an average rate of 5.50% in 2024.The Company's intercompany payables primarily reflect intercompany balances due to affiliates as of December 31, 2024. During the year ended December 31, 2024, the Company settled the majority of outstanding intercompany payables via non-cash capital transactions.Note 4 - The Company guaranteed approximately $9.4 billion primarily related to intercompany indebtedness and financial obligations of certain direct and indirect wholly-owned subsidiaries. There were immaterial liabilities required for these guarantees as of December 31, 2024. Note 5 - In February 2024, as part of our existing share repurchase program, we entered into separate accelerated share repurchase agreements with Deutsche Bank AG and Bank of America, N.A. to repurchase $3.2 billion of common stock in aggregate. The total number of shares of our common stock repurchased under the agreements was approximately 9.3 million.

FS-6

 THE CIGNA GROUP AND SUBSIDIARIES

SCHEDULE IIVALUATION AND QUALIFYING